MYOCET

This brand name is authorized in Austria, Croatia, Cyprus, Estonia, Finland, France, Ireland, Italy, Lithuania, Netherlands, Poland, Romania, Spain.

Active ingredients

The drug MYOCET contains one active pharmaceutical ingredient (API):

1	Doxorubicin UNII 82F2G7BL4E - DOXORUBICIN HYDROCHLORIDE
	Doxorubicin is a cytotoxic anthracycline antibiotic obtained from Streptomyces peucetius var. caesius. The exact mechanism of the antitumour activity of doxorubicin is not known. It is generally believed that inhibition of DNA, RNA and protein synthesis is responsible for the majority of the cytotoxic effects.
	Read more about Doxorubicin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L01DB01	Doxorubicin	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01D Cytotoxic antibiotics and related substances → L01DB Anthracyclines and related substances
Discover more medicines within L01DB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1212398, 1598003
ES	Centro de información online de medicamentos de la AEMPS	00141001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	003099
FR	Base de données publique des médicaments	68974273
IT	Agenzia del Farmaco	035189012
LT	Valstybinė vaistų kontrolės tarnyba	1029920, 1065432
NL	Z-Index G-Standaard, PRK	77984
PL	Rejestru Produktów Leczniczych	100133608
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W69351001